da Vinci systems

Intuitive Surgical beat Q1 earnings estimates with $2.77B revenue and $2.50 EPS, raising Da Vinci guidance. Stock up 2.13% despite Asia weakness and bariatric procedure declines.

$ISRG has averaged 21% annual gains over the past decade. Robotic surgery procedures grew 18% YoY, positioning the stock as a potential long-term wealth builder despite premium valuations.

Intuitive Surgical posted strong Q4 results with 19% revenue growth, but 2026 guidance signals meaningful deceleration. At 63x earnings, stock appears fairly valued for current shareholders but overvalued for new investors.